Stock BUX BIOMARK DIAGNOSTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Biomark Diagnostics Inc. Canadian Securities Exchange

Equities

BUX

CA09073K1084

Market Closed - Canadian Securities Exchange
Other stock markets
 20:38:22 24/06/2024 BST 		5-day change 1st Jan Change
0.235 CAD -2.08% Intraday chart for Biomark Diagnostics Inc. -2.08% -7.84%
02-29 Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
02-28 BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biomark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
BioMark Diagnostics Inc. Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities
Biomark Diagnostics Inc. Appoints Theresa Peterson as Member of Advisory Team
Biomark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
BioMark Diagnostics Inc. Appoints Randolph Ford to its Strategic Advisory Team
Biomark Diagnostics Inc. Appoints Kevin J. Cosgriff to Its Strategic Advisory Team
Biomark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
Biomark Diagnostics Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
BioMark Diagnostics Inc. Announces Update from Ongoing Clinical Trial Using its Lung Cancer Liquid Biopsy Test as it Prepares for Commercial Launch
BioMark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Biomark's Glioblastoma Study Published in Cancers Demonstrates Inhibiting SAT1 Sensitized Cancer Cells Towards Radiation and Chemotherapy
BioMark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022
BioMark Diagnostics Inc. Reports Earnings Results for the Full Year Ended March 31, 2022
BioMark Diagnostics Inc. Auditor Raises 'Going Concern' Doubt
BioMark Diagnostics and the Icahn School of Medicine At Mount Sinai Announce Partnership to Advance Early Lung Cancer
BioMark Diagnostics Inc. Announces Update on Company Outlook for 2022
BioMark Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
BioMark participera avec Astrazeneca, Pfizer Canada et la Fondation de l'IUCPQ à un projet de 3,5 m$ pour améliorer la détection précoce du cancer du poumon
BioMark Diagnostics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 20B Stock
  4. BUX Stock
  5. News Biomark Diagnostics Inc.
  6. Other languages